Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
6,500,794
-
Total 13F shares
-
7,948,739
-
Share change
-
+1,301,792
-
Total reported value
-
$289,411,000
-
Price per share
-
$36.41
-
Number of holders
-
48
-
Value change
-
+$46,126,360
-
Number of buys
-
32
-
Number of sells
-
18
Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (the "Shares") (FBRX) as of Q4 2020
As of 31 Dec 2020 Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (the "Shares") (FBRX) had 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 7,948,739 shares of stock of the company.
Largest 10 holders included ArrowMark Colorado Holdings LLC, FRANKLIN RESOURCES INC, BVF INC/IL, FRED ALGER MANAGEMENT, LLC, CITADEL ADVISORS LLC, PERCEPTIVE ADVISORS LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, Invesco Ltd., Woodline Partners LP, and BlackRock Inc..
This table shows 48 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.